Skip to main content
logo
Outlook Therapeutics, Inc. (OTLK)
NASDAQ: OTLK · Real-Time Price · USD
1.830
+0.250 (15.82%)
At close: Jun 22, 2026, 4:00 PM EDT
1.870
+0.040 (2.19%)
After-hours: Jun 22, 2026, 7:34 PM EDT

Outlook Therapeutics Income Statement

Millions USD. Fiscal year is Oct - Sep.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Sep '25 Sep '24 Sep '23 Sep '22 Sep '21
Revenue
0.331.41----
Cost of Revenue
1.541.36----
Gross Profit
-1.20.06----
Selling, General & Admin
38.1239.9429.9426.6720.7412.77
Research & Development
21.2527.1841.7626.4542.3338.96
Total Operating Expenses
59.3767.1271.753.1363.0751.73
Operating Income
-60.57-67.06-71.7-53.13-63.07-51.73
Interest Income
-0.090.910.97--
Interest Expense
-0.05-0.28-3.16-2.53-1.49-0.94
Other Non-Operating Income (Expense)
-1.713.28-1.41-4.29-1.49-0.5
Total Non-Operating Income (Expense)
-1.763.08-3.66-5.85-2.98-1.43
Pretax Income
-39.45-63.98-75.36-58.98-66.05-53.16
Provision for Income Taxes
-1.55-1.550000
Net Income
-60.96-62.42-75.37-58.98-66.05-53.16
Net Income to Common
-60.96-62.42-75.37-58.98-66.05-53.16
Shares Outstanding (Basic)
57351913118
Shares Outstanding (Diluted)
57351913118
Shares Change (YoY)
116.84%87.59%48.29%17.96%38.91%110.43%
EPS (Basic)
-1.17-1.79-4.06-4.72-6.20-7.00
EPS (Diluted)
-1.17-1.79-4.06-4.72-6.20-7.00
Free Cash Flow
-47.05-51.83-68.79-42.97-56.67-54.25
Free Cash Flow Per Share
-0.83-1.49-3.71-3.44-5.34-7.11
Gross Margin
-360.85%4.05%----
Operating Margin
-18182.80%-4744.25%----
Profit Margin
-18297.50%-4416.22%----
FCF Margin
-14121.80%-3666.65%----
EBITDA
-60.45-66.94-71.59-53.08-62.87-51.46
EBITDA Margin
-18146.80%-4735.97%----
EBIT
-60.57-67.06-71.7-53.13-63.07-51.73
EBIT Margin
-18182.80%-4744.25%----
Effective Tax Rate
3.94%2.43%-0.00%-0.00%-0.00%-0.00%
SEC Filings: 10-K · 10-Q